Gsk (GSK) Net Income towards Common Stockholders (2009 - 2026)
Gsk (GSK) reported Net Income towards Common Stockholders of $2.07 billion for the quarter ended Sep 30, 2026, down 23.7% from $2.72 billion a year earlier but up 255.2% from the prior quarter.
Gsk (GSK) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Gsk's Net Income towards Common Stockholders came in at $12.6 billion, up 74.6% year-over-year; for the year ended Dec 31, 2025, it was $7.54 billion, up 129.0% from the prior year.
- Net Income towards Common Stockholders has a five-year compound annual growth rate of 0.4% (years ended Dec 2020 to Dec 2025).
- By year, Net Income towards Common Stockholders came in at $3.29 billion in the year ended Dec 31, 2024 (-46.3%), $6.13 billion in the year ended Dec 31, 2023 (-66.9%), $18.51 billion in the year ended Dec 31, 2022 (+206.8%) and $6.03 billion in the year ended Dec 31, 2021 (-18.3%).
- Five-year quarterly Net Income towards Common Stockholders spans a low of -$75.36 million in the quarter ended Sep 30, 2024 and a high of $12.75 billion in the quarter ended Sep 30, 2022.
- Year over year, Net Income towards Common Stockholders gained in four of the last six quarters, with growth averaging 4.6%.
- The high point for year-over-year Net Income towards Common Stockholders in five years was the quarter ended Sep 30, 2022 (growth of 692.0%); the low point was the quarter ended Sep 30, 2023 (a decline of 85.5%).
- Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at $583.63 million (quarter ended Jun 30, 2026), $2.34 billion (quarter ended Mar 31, 2026) and $7.6 billion (quarter ended Dec 31, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | 2.07 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.07 Bn |
| Jun 30, 2026 | 583.63 Mn |
| Mar 31, 2026 | 2.34 Bn |
| Dec 31, 2025 | 7.60 Bn |
| Sep 30, 2025 | 2.72 Bn |
| Jun 30, 2025 | 1.93 Bn |
| Mar 31, 2025 | 2.05 Bn |
| Dec 31, 2024 | 531.37 Mn |
| Sep 30, 2024 | -75.36 Mn |
| Jun 30, 2024 | 1.48 Bn |
| Mar 31, 2024 | 1.33 Bn |
| Dec 31, 2023 | 434.40 Mn |
| Sep 30, 2023 | 1.85 Bn |
| Jun 30, 2023 | 2.03 Bn |
| Mar 31, 2023 | 1.81 Bn |
| Dec 31, 2022 | 1.75 Bn |
| Sep 30, 2022 | 12.75 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 2.42 Bn |
| Dec 31, 2021 | 1.01 Bn |
Gsk Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();